Department of Microbiology, Institut Pasteur, F-75015 Paris, France.
Collège Doctoral, Sorbonne Université, F-75005 Paris, France.
Viruses. 2018 Jun 15;10(6):327. doi: 10.3390/v10060327.
Phage therapy is based on a simple concept: the use of a virus (bacteriophage) that is capable of killing specific pathogenic bacteria to treat bacterial infections. Since the pioneering work of Félix d’Herelle, bacteriophages (phages) isolated in vitro have been shown to be of therapeutic value. Over decades of study, a large number of rather complex mechanisms that are used by phages to hijack bacterial resources and to produce their progeny have been deciphered. While these mechanisms have been identified and have been studied under optimal conditions in vitro, much less is known about the requirements for successful viral infections in relevant natural conditions. This is particularly true in the context of phage therapy. Here, we highlight the parameters affecting phage replication in both in vitro and in vivo environments, focusing, in particular, on the mammalian digestive tract. We propose avenues for increasing the knowledge-guided implementation of phages as therapeutic tools.
利用能够杀死特定病原菌的病毒(噬菌体)来治疗细菌感染。自 Félix d'Herelle 的开创性工作以来,已经证明在体外分离的噬菌体具有治疗价值。经过几十年的研究,已经破译了噬菌体用于劫持细菌资源并产生其后代的大量相当复杂的机制。虽然已经确定了这些机制,并在体外的最佳条件下进行了研究,但对于成功的病毒感染在相关自然条件下的要求知之甚少。在噬菌体疗法的背景下尤其如此。在这里,我们重点介绍了影响噬菌体在体外和体内环境中复制的参数,特别是关注哺乳动物的消化道。我们提出了增加噬菌体作为治疗工具的知识引导实施的途径。